Not applicableStudy completedNCT04152941What this trial is testingReal-life Data of Olaparib in Relapsed Ovarian Cancers PatientsWho this might be right forRelapsed Ovarian Cancers Patients ARCAGY/ GINECO GROUP 130
Early research (Phase 1)Study completedNCT01220154What this trial is testingStudy of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more David O'Malley 9
Testing effectiveness (Phase 2)Study completedNCT00671788What this trial is testingA Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma Gynecologic Oncology Group 35
Not applicableLooking for participantsNCT05236686What this trial is testingSurvival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma Shanghai Gynecologic Oncology Group 94
Testing effectiveness (Phase 2)Ended earlyNCT03029585What this trial is testingPhase II Study of Intraperitoneal NanoPac® in Patients With Ovarian CancerWho this might be right forOvarian Carcinoma NanOlogy, LLC 10
Large-scale testing (Phase 3)Study completedNCT00028743What this trial is testingCombination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer NCIC Clinical Trials Group 819
Not applicableUnknownNCT03015376What this trial is testingInherited Susceptible Genes Among Epithelial Ovarian CancerWho this might be right forOvarian Neoplasm EpithelialHereditary Breast and Ovarian Cancer Syndrome Peking Union Medical College Hospital 1,000
Testing effectiveness (Phase 2)WithdrawnNCT04276597What this trial is testingPhase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.Who this might be right forPulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more Excel Diagnostics and Nuclear Oncology Center
Not applicableStudy completedNCT01216813What this trial is testingStudy of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more Royal Marsden NHS Foundation Trust 33
Not applicableWithdrawnNCT05991752What this trial is testingHealth-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized TrialWho this might be right forEpithelial Ovarian Cancer University Hospital, Tours
Not applicableStudy completedNCT00248547What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantWho this might be right forCancer OHSU Knight Cancer Institute 40
Early research (Phase 1)Study completedNCT00003597What this trial is testingColony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsWho this might be right forCancer Children's Oncology Group 16
Early research (Phase 1)Study completedNCT01588678What this trial is testingA Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or LymphomasWho this might be right forAdvanced Solid TumorLymphoma Daiichi Sankyo 32
Early research (Phase 1)Not Yet RecruitingNCT07674615What this trial is testingIMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancersPrimary+1 more Shanghai Gynecologic Oncology Group 19
Not applicableStudy completedNCT01170299What this trial is testingLow-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerWho this might be right forAnal CancerBladder CancerCervical Cancer+6 more Royal Marsden NHS Foundation Trust 177
Testing effectiveness (Phase 2)WithdrawnNCT00562185What this trial is testingDoxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian CancerWho this might be right forOvarian Cancer University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT00002568What this trial is testingCombination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerWho this might be right forOvarian Cancer Gynecologic Oncology Group 470
Early research (Phase 1)Study completedNCT03219268What this trial is testingMGD013 in Patients With Unresectable or Metastatic NeoplasmsWho this might be right forAdvanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more MacroGenics 277
Early research (Phase 1)Ended earlyNCT00003926What this trial is testingAmifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more Masonic Cancer Center, University of Minnesota 13
Not applicableNo Longer AvailableNCT03874455What this trial is testingTazemetostat Expanded Access Program for Adults With Solid TumorsWho this might be right forEpithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more Epizyme, Inc.